Mark Pollack
Overview
Explore the profile of Mark Pollack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stevens S, Boley R, Pollack M, Hobfoll S, Shankman S, Pinkerton L, et al.
J Affect Disord
. 2024 Jul;
362:258-262.
PMID: 38971192
Neuropeptide Y (NPY) is a 36-amino acid peptide that is widely expressed throughout the limbic system. Recent evidence has highlighted NPY as a marker of resilience to posttraumatic psychopathology, which...
2.
Tirone V, Smith D, Steigerwald V, Bagley J, Brennan M, Van Horn R, et al.
J Interpers Violence
. 2020 Jan;
36(23-24):10989-11008.
PMID: 31898925
Sexual revictimization refers to exposure to more than one incident of rape and is a known risk factor for poor mental health among civilians. This construct has been understudied among...
3.
Thompson H, Hill K, Jadhav R, Webb T, Pollack M, Karnik N
J Addict Med
. 2019 Nov;
13(6):460-463.
PMID: 31689260
Objective: In 2017, an academic health center in Chicago launched the multidisciplinary Substance Use Intervention Team (SUIT) to address opioid misuse across 18 inpatient units and in a new outpatient...
4.
Thompson H, Faig W, Gupta N, Lahey R, Golden R, Pollack M, et al.
Psychiatr Serv
. 2019 Apr;
70(7):604-607.
PMID: 31023189
Objective: This study analyzed effectiveness of screening, referrals, and treatment uptake of a collaborative care for depression intervention across 10 primary care clinics in Chicago. Methods: Between November 2016 and...
5.
Manning J, Reynolds G, Saygin Z, Hofmann S, Pollack M, Gabrieli J, et al.
PLoS One
. 2015 May;
10(4):e0125286.
PMID: 25928647
We investigated differences in the intrinsic functional brain organization (functional connectivity) of the human reward system between healthy control participants and patients with social anxiety disorder. Functional connectivity was measured...
6.
Doehrmann O, Ghosh S, Polli F, Reynolds G, Horn F, Keshavan A, et al.
JAMA Psychiatry
. 2012 Sep;
70(1):87-97.
PMID: 22945462
Context: Current behavioral measures poorly predict treatment outcome in social anxiety disorder (SAD). To our knowledge, this is the first study to examine neuroimaging-based treatment prediction in SAD. Objective: To...
7.
Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, et al.
Psychother Psychosom
. 2012 Jan;
81(2):87-97.
PMID: 22286203
Background: We assessed the efficacy of low-dose aripiprazole added to antidepressant therapy (ADT) in major depressive disorder (MDD) patients with inadequate response to prior ADT. Methods: As per the sequential...
8.
George M, Ward Jr H, Ninan P, Pollack M, Nahas Z, Anderson B, et al.
Brain Stimul
. 2010 Jul;
1(2):112-21.
PMID: 20633378
Background: Vagus nerve stimulation (VNS) is an effective anticonvulsant device and has shown antidepressant effects in chronic treatment resistant depression. Because the vagus nerve sends information to brain regions important...
9.
Pollack M, Kinrys G, Krystal A, McCall W, Roth T, Schaefer K, et al.
Arch Gen Psychiatry
. 2008 May;
65(5):551-62.
PMID: 18458207
Context: Insomnia and generalized anxiety disorder (GAD) are prevalent disorders that may coexist. Objective: To determine the efficacy of eszopiclone combined with escitalopram oxalate in treating insomnia comorbid with GAD....
10.
Pollack M, Mangano R, Entsuah R, Tzanis E, Simon N, Zhang Y
Psychopharmacology (Berl)
. 2007 Jun;
194(2):233-42.
PMID: 17589833
Rationale: Few randomized, placebo-controlled trials have evaluated the comparative efficacy and tolerability of more than one pharmacological agent for panic disorder. Objectives: The primary objective of this study was to...